FDA Approved: CEFPODOXIME PROXETIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for cefpodoxime proxetil from Aurobindo Pharma Limited, marking a regulatory action on this generic antibiotic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Bronchitis
• Otitis Media
• Skin and Skin Structure Infections
• Urinary Tract Infection

Drugs mentioned

• CEFPODOXIME PROXETIL (CEFPODOXIME PROXETIL)

Snippet

SUPPL AP for CEFPODOXIME PROXETIL (CEFPODOXIME PROXETIL)